It has been well described that acute COVID-19 disease, in up to 50% of patients, is associated with a reduction in lymphocyte count, in particular the absolute counts of T lymphocytes (CD4+ and CD8+), suggesting that T cell immune function of COVID-19 patients is weakened [26] and associated with poor outcomes [27]. This evidence concerns the gene CD8A and COVID-19.